Proposal for the 2024 Chinese guideline for diagnosis and treatment of depressive disorders
10.3760/cma.j.cn113661-20230919-00076
- VernacularTitle:《中国抑郁障碍防治指南》（2024年版）计划书
- Author:
Gang WANG
1
;
Yuan FENG
;
Jin LIU
;
Nan LI
;
Siyan ZHAN
;
Yiru FANG
;
Zhijian YAO
;
Han RONG
;
Xiaoping WANG
;
Ling ZHANG
;
Lingjiang LI
Author Information
1. 首都医科大学附属北京安定医院，北京100088
- Publication Type:Journal Article
- Keywords:
Depressive disorders;
Guideline;
Proposal
- From:
Chinese Journal of Psychiatry
2023;56(6):407-412
- CountryChina
- Language:Chinese
-
Abstract:
Aiming to improve the standardized screening, diagnosis, and treatment of depressive disorders in China, promote the standardization of clinical practice, and enhance the prevention and intervention of depressive disorders in China, the Chinese Society of Psychiatry of the Chinese Medical Association, and the National Center for Mental Disorders & the National Clinical Research Center for Mental Disorders(affiliated with The Second Xiangya Hospital of Central South University and Beijing Anding Hospital, Capital Medical University)have jointly initiated the Chinese Guideline for the Diagnosis and Treatment of Depressive Disorders: 2024 Edition. The Peking University Center for Evidence-Based Medical and Clinical Research will provide methodological support. The Guidelines Development Committee will follow international standards for developing and reporting guidelines, build a multidisciplinary team of experts, and adopt the GRADE method to develop an evidence-based guideline for the prevention and management of depressive disorders in China. This proposal introduces the significance and purpose of developing a new edition of the guideline, the methods of evidence retrieval and quality evaluation, the process of guideline development, and the plan for publication, implementation, and dissemination of the guideline.
